Members Members Residents Job Board
Join Today Renew Your Membership Make A Donation
2007 Posters: The Impact of F-18 Fdg Positron Emission Tomography (Fdg-PET) for the Preoperative Management of Patients with Colorectal Cancer
2007 Program and Abstracts | 2007 Posters
The Impact of F-18 Fdg Positron Emission Tomography (Fdg-PET) for the Preoperative Management of Patients with Colorectal Cancer
Zafer Kilbas*1, Taner Yigit1, Seyfettin Ilgan2, Nuri Arslan2, Oner Mentes1, Koksal Oner1, Orhan Kozak1, Turgut Tufan1
1Dep. of General Surgery, Gulhane Military Medical Academy, Ankara, Turkey; 2Dep. of Nuclear Medicine, Gulhane Military Medical Academy, Ankara, Turkey

Whole-body FDG-PET has proved effective in the diagnosis of recurrent colorectal cancer and in the monitoring of cancer therapy.In this study, we analysed how FDG-PET affects the management of patients with colorectal cancer in the preoperative period. We aimed to evaluate the potential role of FDG-PET in the diagnosis of primary cancer, detection of locoregionel lymph node and distant metastases. A prospective study of 26 patients, with histologically diagnosed or clinically high-suspected colorectal cancer, was undertaken. Patients were evaluated by conventionel imaging methods (chest X-ray, multislice computed tomography and colonoscopy) and FDG-PET. The results of these investigations were compared independently.FDG-PET detected 28 primary colorectal tumors in 26 patients. (3 patients had syncronous tumors) while CT detected only 19. FDG-PET had a sensitivity of 96% and positive predictive value of 100% for the diagnosis of primary cancer. On the other hand, CT had a sensitivity of 68% and positive predictive value of 95% (p<0,05). There was no difference between FDG-PET and CT in detecting the locoregionel lymph nodes and hepatic metastases. There was a statistically significant difference in the evaluation of extrahepatic distant metastases. FDG-PET detected 10 unexpected extrahepatic distant metastases in 2 patients and had a sensitivity of 89% for detecting additional metastatic disease, whereas CT had 33%. FDG-PET resulted in altered management for 8 patients of whom 3 avoided inappropriate surgery. Of this 8 patients; 1 was underwent paliative resection because of unexpected metastases and 2 were underwent extended resection because of syncronous tumors. It is concluded that whole-body FDG-PET is highly sensitive for the diagnosis and staging of patients with colorectal cancer. Especially FDG-PET is superior to CT for the detection of distant metastases at all sites except the liver. Its use in conjunction with CT result in a more accurate selection of patients for surgical treatment with curative intent.


2007 Program and Abstracts | 2007 Posters


Society for Surgery of the Alimentary Tract

Facebook Twitter YouTube

Email SSAT Email SSAT
500 Cummings Center, Suite 4400, Beverly, MA 01915 500 Cummings Center
Suite 4400
Beverly, MA 01915
+1 978-927-8330 +1 978-927-8330
+1 978-524-0498 +1 978-524-0498
Links
About
Membership
Publications
Newsletters
Annual Meeting
Join SSAT
Job Board
Make a Pledge
Event Calendar
Awards